Overall, our data suggest that TLK expression is functionally linked to PARPi sensitivity in BRCA1-mutant cells and highlight the role of TLK proteins in modulating the anticancer effects of PARP inhibition, particularly in challenging cancer types such as TNBC and HGSOC. The gene discussed is BRCA1; the disease is cancer.